TRML
Price:
$47.98
Market Cap:
$1.23B
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
Industry
Biotechnology
IPO Date
2021-05-07
Stock Exchange
NASDAQ
Ticker
TRML
According to Tourmaline Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 24.68. This represents a change of -23.52% compared to the average of 32.26 of the last 4 quarters.
The mean historical Current Ratio of Tourmaline Bio, Inc. over the last ten years is 23.42. The current 24.68 Current Ratio has changed 10.44% with respect to the historical average. Over the past ten years (40 quarters), TRML's Current Ratio was at its highest in in the March 2024 quarter at 62.17. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
23.42
Median
23.99
Minimum
0.40
Maximum
44.29
Discovering the peaks and valleys of Tourmaline Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.43%
Maximum Annual Current Ratio = 44.29
Minimum Annual Increase = -99.10%
Minimum Annual Current Ratio = 0.40
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 30.18 | -27.74% |
| 2023 | 41.76 | 584.75% |
| 2022 | 6.10 | 1.43% |
| 2021 | 0.40 | -99.10% |
| 2020 | 44.29 | 148.71% |
The current Current Ratio of Tourmaline Bio, Inc. (TRML) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
26.01
5-year avg
24.54
10-year avg
23.42
Tourmaline Bio, Inc.’s Current Ratio is less than Terns Pharmaceuticals, Inc. (24.70), greater than Precigen, Inc. (0), greater than Immatics N.V. (7.36), greater than ORIC Pharmaceuticals, Inc. (14.65), less than Enliven Therapeutics, Inc. (32.58), greater than Amylyx Pharmaceuticals, Inc. (13.70), greater than Relay Therapeutics, Inc. (19.14), greater than Dianthus Therapeutics, Inc. (17.35), greater than Wave Life Sciences Ltd. (2.51), greater than Syndax Pharmaceuticals, Inc. (4.64),
| Company | Current Ratio | Market cap |
|---|---|---|
| 24.70 | $2.44B | |
| 0 | $1.13B | |
| 7.36 | $1.44B | |
| 14.65 | $1.11B | |
| 32.58 | $1.27B | |
| 13.70 | $1.20B | |
| 19.14 | $1.39B | |
| 17.35 | $1.62B | |
| 2.51 | $1.25B | |
| 4.64 | $1.71B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tourmaline Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tourmaline Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tourmaline Bio, Inc.'s Current Ratio?
How is the Current Ratio calculated for Tourmaline Bio, Inc. (TRML)?
What is the highest Current Ratio for Tourmaline Bio, Inc. (TRML)?
What is the 3-year average Current Ratio for Tourmaline Bio, Inc. (TRML)?
What is the 5-year average Current Ratio for Tourmaline Bio, Inc. (TRML)?
How does the current Current Ratio for Tourmaline Bio, Inc. (TRML) compare to its historical average?